Company Overview and News
WallStars all have positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Government Properties showed highest yield.
ORC ASHFP MITT CIM AHT.WI EARN TWO AGNC WMC AJXA GOV MFO DX GOVNI MFA SIR GNL IVR AJX AHT
2018-10-15 seekingalpha - 1
Following continued requests, this article analyzes MAIN’s dividend sustainability by performing three tests based on recent historical and projected future quarterly results.
AIY AINV FSIC MAIN MCQ AIB MCV OSLE PSEC OCSL MSCA.CL MCX SLRC MSCA TWO PBB SLRA MCC
I am projecting AGNC will report a combined notable net unrealized loss on available-for-sale securities and investment securities measured at FMV for the third quarter of 2018.
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW WMC NRZ AIC CYS TRI MTGE MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC HTS IVR NYMT FMCCS FMCCT
Fairly similar to the prior quarter, I am projecting AGNC will report a modest-notable gain regarding the company’s derivative instruments and other securities for the third quarter of 2018.
NYMTO ORC CHMI NYMTP AI TWO AGNC AIW NRZ AIC NLY CYS ARR NYMT
2018-10-05 sec.gov - 1
Document UNITED STATES
Three 2x Leveraged High-Yield Monthly Pay Mortgage REIT ETNs all have very high yields, but at times may trade at prices which may present risk-free arbitrage opportunities.
SLDA DTK RC ABRN REM CMO TWO 8685 GPMT AJXA HASI ABR CEFL AVF DX AIG ABRN.CL AJX
Document UNITED STATES
2018-10-01 seekingalpha - 1
There is much uncertainty as to the future path of the equity and bond markets. This suggests diversification may be more important than usual.
STAR DTK ORC ABRN REM UBS CMO TWO AGNC HASI ABR AAL DX ARR ABRN.CL ULSGF
2018-09-28 sec.gov - 2
2018-09-24 seekingalpha - 1
This article compares NLY’s recent dividend per share rates, yield percentages, and several dividend sustainability metrics to 19 mREIT peers.
ANH NYMTO ORC CHMI NYMTP AI CIM CMO TWO AGNC AIW GPMT MO WMC NRZ AIC CYS 511505 CAPITALT MITT MFO DX NLY ARR BXMT MFA IVR NYMT
WallStars show positive broker target price upsides. IRSA Propiedades flaunted top net gains, while Government Properties showed the highest yield.
GEO ORC ASHFP CHMI CYORP CIM AHT.WI TWO AGNC CIO AJXA GOV NRZ MFO GLPI GOVNI MFA SIR AJX AHT
Following continued requests by readers, this article analyzes fixed-rate agency MBS price movements during the third quarter of 2018 (through 9/14/2018).
NYMTO ORC FNMA CHMI NYMTP CIM AI TWO AGNC AIW MO WMC NRZ AIC CYS TRI MITT FMCKI FMCKJ FMCCO FMCCP FMCCM FMCCN MFO FMCCI DX NLY FMCCJ FMCCG FMCKO FMCKP FMCKM FMCKN FMCKK FMCKL ARR MFA FMCC IVR NYMT FMCCS FMCCT
WallStars show positive broker target-price-upsides. 15 of 80 were tagged as "safer" for dividends because they showed positive one-year returns and free-cash-flow-yields greater than their dividend-yields 9/14/18.
CPLP SXCP ANH ORC SUN TWO SNMP TCRX DX NLY SFL TCRD TCRZ TSLF GMLP SIR GPP
2018-09-18 sec.gov - 2
2018-10-01 - Asif
Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...
2018-09-25 - Asif
Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...
2018-09-18 - Asif
Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...
Silicon Investor Message Boards
This table lists all message boards related to TWO / Two Harbors Investment Corp. on message board site Silicon Investor.
as of ET